Protected percutaneous coronary intervention - a new road for success in treating complex patients.

Postepy Kardiol Interwencyjnej · 2016 · PMC5011534 · PMID 27625681

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

At the mandatory 90-day follow-up, a strong trend was observed towards a decreased major adverse event rate in Impella 2.5-supported patients compared to IABP-supported patients.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.